Pancragen

Pancragen (Lys-Glu-Asp-Trp, KEDW) is a synthetic tetrapeptide (MW ~562.6 g/mol) from the Khavinson bioregulatory peptide family, designed as a pancreas-specific bioregulator. It is proposed to restore beta-cell function, improve insulin secretion, and normalize glucose metabolism in aging or metabolic disease. Published primarily in Russian biogerontology literature.

Category: Metabolic / Anti-Aging. Evidence rating: D (animal/preclinical only).

Clinical status: Russian clinical studies in patients with metabolic syndrome and type 2 diabetes. Not validated in Western trials.

Pancragen is proposed to interact with DNA regulatory sequences in pancreatic cells, particularly beta-cells, modulating expression of genes involved in insulin synthesis, glucose sensing, and beta-cell survival. In animal models of diabetes and aging, it reportedly improved glucose tolerance and…

Safety considerations: Reported as well-tolerated; No serious adverse events in published literature; Monitor blood glucose when used alongside antidiabetic medications.

Reviewed by the PeptideAtlas Editorial Team.

Pancragen — measured properties

Amino-acid sequenceLys-Glu-Asp-Trp (KEDW)
Molecular weight~562.6 g/mol
Half-life~20-40 minutes
Production methodsynthetic
Anti-doping statusnot-listed
US regulatory statusResearch peptide. Not FDA-approved.

Frequently asked questions

Can Pancragen replace diabetes medications?

No. Pancragen is an experimental research peptide with limited evidence. It should never replace prescribed diabetes medications. If you have diabetes, continue working with your endocrinologist.

What is PANCRAGEN?

Pancragen is a Khavinson bioregulator tetrapeptide researched for pancreatic tissue support and beta-cell function, with potential applications in metabolic health and glucose regulation.

What are the research benefits of PANCRAGEN?

PANCRAGEN has been studied for: Pancreatic tissue support, Beta-cell function, Glucose metabolism, Age-related metabolic support. Khavinson bioregulator; pancreas/metabolic focus.

How does PANCRAGEN work?

Tetrapeptide bioregulator that may interact with gene promoter regions in pancreatic cells, modulating expression of proteins involved in insulin secretion and beta-cell maintenance.